Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FiteBac Technology and Siltech Team to Manufacture Novel Antimicrobial Silsesquioxanes with Advanced Properties


News provided by

KHG FiteBac Technology

Jun 02, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Partnering with Siltech
Partnering with Siltech

After the successful launch of multiple FDA-cleared antimicrobial dental devices, FiteBac partners with Siltech, an international corporation specializing in innovative silicone products, to develop novel materials imbued with FiteBac's broad antimicrobial effectiveness.

MARIETTA, Ga., June 2, 2022 /PRNewswire-PRWeb/ -- FiteBac Technology is partnering with Siltech to expand its line of antimicrobial additives with novel super nanoparticles or silsesquioxanes. FiteBac's 50 nm and 200 nm functionalized silica particles provide extensive crosslinking of silsesquioxanes in multiple polymer and resin systems. FiteBac silsesquioxanes enhance strength, durability, and resiliency, and provide biocidal effects: all of this allows materials made today to be better and safer tomorrow. The incorporation of FiteBac's chemical additives, functionalized silica, and silsesquioxanes into coatings, composites, and carbon fibers will yield lighter, stronger, and more durable materials for applications in aerospace, medicine, dentistry, transportation, 3D printing, and additive manufacturing.

Over the past 10 years, FiteBac's founder, Dr. Kirk Kimmerling, and a team of over 40 scientists and dental researchers have brought FiteBac to the forefront of antimicrobial technology. FiteBac's team has been cited in over 20 scientific publications, received multiple patents, and successfully launched multiple FDA-cleared antimicrobial dental devices. FiteBac lead molecules K21 and K18 are positioned with the FDA Drug and Device divisions to provide even greater impacts in healthcare very soon.

"Our advanced antimicrobial silsesquioxanes will assist in the development of biofilm-inhibiting permanent medical and dental devices, such as dental and orthopedic implants,” stated FiteBac’s founder, Dr. Kirk Kimmerling.

Post this

The global FiteBac initiative continues to grow as more scientists from universities and industries throughout the world create diverse applications of FiteBac Technology in fields as varied as composites, coatings, textiles, and pharmaceuticals. With FiteBac and silane specialist Siltech partnering together, they have created large-scale, efficient production of FiteBac's chemistry which will include advanced POSS (Polyhedral Oligomeric Silsesquioxane) materials. Unlike other silsesquioxanes, FiteBac's proprietary processes provide higher degrees of functionality throughout the nano silicate complex, affording greater integration into the material systems as well as biocidal effectiveness.

Greater material integration and denser particles will allow for the development of new systems with new, desirable mechanical properties.

"Working with the FiteBac team and this novel antimicrobial approach has brought exciting opportunities for Siltech," said Bob Ruckle, Marketing and Sales Director at Siltech. "Our chemists and other R&D personnel are working to maximize the potential of FiteBac's revolutionary chemistry. We see the enormous impact FiteBac Chemistry stands to have on multiple fields - but especially on healthcare - and we're excited to be a key part of this pioneering process."

"FiteBac is so grateful that a leader in silicone technology like Siltech has invested so many resources to scale our chemistry,'' said FiteBac's founder, Dr. Kirk Kimmerling. "Siltech's manufacturing will provide cost-effective drugs and additives into many medical and dental devices, creating a healthier world. Our advanced antimicrobial silsesquioxanes will assist in the development of biofilm-inhibiting permanent medical and dental devices, such as dental and orthopedic implants."

About FiteBac Technology
FiteBac Technology is a family of brands, all specializing in diverse applications of their patented, versatile antimicrobial technology. In 2020, FiteBac Dental became the first company to release an FDA-cleared Antimicrobial Cavity Cleanser. Today, FiteBac is using its technology in the development of new products offering customers and patients lasting antimicrobial protection: resins, polymers, composites, coatings, silica binders, silicones, and textiles.

About Siltech
With more than 25 years of experience, Siltech is an industry leader in the world of silicones. Their expertise includes organo-modified silicone surfactants and silicone polymers, including a full line of cationic, quaternary, and di-functional silicones, as well as a number of reactive silicones. In these fields, Siltech owns more than 30 patents and serves a variety of industries like personal care, foam, automotive, inks, coatings, household chemicals, industrial chemicals, pulp and paper, agriculture, composites, leather, mould release, oil and gas, and 3D printing.

Media Contact

Kirk Kimmerling, DDS, Founder, KHG FiteBac Technology, 1 7708517212, [email protected]

SOURCE KHG FiteBac Technology

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.